[e-mail]

PDL BioPharma: High Dividend Biotech Stock

FACT will not pay dividends.

You missed the negative that the royalty flows to PDLI have an expiration, at expiration, no more dividend, no more company, they liquidate. You have to factor this into your math.

Onyx Pharmaceuticals: Good Reasons for Raising Capital, Investors Overly Concerned

The trouble is onxx will take that money they just raised and acquire something and chances are it won't be accretive to earnings. Like it or not onxx is valued on current eps. Its obvious they raised money to spend it. Onxx stock won't do much for the time being while people wait to see what they do and will expect them to do something foolish.

Roche's Race for Genentech is On

If the market thought Roche was going to increase its offer wouldn't the shares be trading for more than 86.50 not $3 under?

Tip for Roche: Use Non-Cash CVRs to Buy Genentech

Roche using CVR's is a great idea. Had they offered something close to $85, with another $10 in a CVR, that may have had a shot at working. Downside risk protected at $85 and some upside if the adjuvant trial works out. As it stands there's 0% chance they'll get to 90%.